Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives.

Patient Relat Outcome Meas · 2018 · PMC6103306 · PMID 30147386

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Corren et al 28 showed that the mean change of ACQ-7 score was modest from baseline to the end of the study (week 16) and the differences between reslizumab and placebo groups did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.